Fig. 1From: A multicentre retrospective observational study on Polish experience of pirfenidone therapy in patients with idiopathic pulmonary fibrosis: the PolExPIR studyAdverse drug reactions (ADRs) categories leading to pirfenidone treatment discontinuationBack to article page